Re:IndieBio SF’s Second Cohort of Biotech Startups
by dnautics on Friday February 05, 2016 @03:48AM
(#11040330)
My prediction: zero of these companies will be around in five years. Gelzen has the best product and is a nice idea, but the material it's replacing is literally waste material from industrial process. Koniku's claim to be the only chip with neurons is flat out false, I can order assays on a multiplexed chip directly reading out electrical impulses from cultured neurons, been on the market for nearly half a decade now.
Myi might have interesting tech, because I trust their cto... But I'm honestly not sure about the other folks involved, in any case diagnostics is going to be very very hard in the next few years.
Re:IndieBio SF’s Second Cohort of Biotech Startups
by xmeson on Sunday February 07, 2016 @12:41AM
(#11051797)
@dnautics where do I order these chips with neurons giving me patch membrane potentials. I really want one of these chips - a link will do. But it has to come with neurons not two sources and i have to culture them. Again, chips, with deliberate microcircuits in 3D with neurons already on it and its a plug and go. Thanks I think you are really awesome if you give me this link. Otherwise you are full of you know what ... :-).
I don't think you can order them, but if you think you're going to be doing computation with neurons, you're an idiot. It'll be overhead like a d-wave, except with zero mathematically validated acceleration instead of maybe making a trip into a small corner of NP.
Please read what I wrote carefully, I said I can order assays. This is koniku's primary market (pharma paying for assays), but they're way behind. Without this source of revenue, they won't be competitive.
Re:IndieBio SF’s Second Cohort of Biotech Startups
by dnautics on Friday February 05, 2016 @02:12PM
(#11043821)
Mostly crap, but I like pembient and maybe Clara foods, they have shots at making it. I really want an abiobot but I don't think their founder will make it. Same with arc reactor. Blue turtle was the fraudster of the group. I know enough about Gaucher disease to know that their proposal was total nonsense.
I'm not harshing on class 1 - probably even with ycombinator, many classes if not all are "mostly crap". Zero, though, is stunning.
Re:IndieBio SF’s Second Cohort of Biotech Startups
by matthewmarkus on Tuesday February 09, 2016 @12:01PM
(#11066726)
Google Alerts has brought this conversation to my attention. If you haven't read our recent thoughts on the issue, I invite you to do so. You can find them here:
Myi might have interesting tech, because I trust their cto... But I'm honestly not sure about the other folks involved, in any case diagnostics is going to be very very hard in the next few years.
I don't think you can order them, but if you think you're going to be doing computation with neurons, you're an idiot. It'll be overhead like a d-wave, except with zero mathematically validated acceleration instead of maybe making a trip into a small corner of NP.
Please read what I wrote carefully, I said I can order assays. This is koniku's primary market (pharma paying for assays), but they're way behind. Without this source of revenue, they won't be competitive.
I'm not harshing on class 1 - probably even with ycombinator, many classes if not all are "mostly crap". Zero, though, is stunning.
https://sosv.com/why-pembient-is-confident-in-synthetic-rhin...
As for IndieBio and the prospects of its class members, I'm sure it is too early to tell. We're flattered, though, to be included in this discussion.